CMPS Company Profile and Key Details

COMPASS Pathways plc (NASDAQ:CMPS) closed at $12.63 USD, gaining $0.10 (0.80%) from the previous close of $12.53. The stock is currently mid-range between its 52-week high and low $2.35 and $14.76. With a market capitalization of about $1.21 billion, COMPASS Pathways plc is classified as a small-cap and shows higher-than-market volatility (beta ~2.51). Key stats such as the average daily volume over the past year has been around 4.13 million shares, in line with its 52-week average. Headquartered in London, None, COMPASS Pathways plc operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Kabir Kumar Nath, the company employs approximately 166 people and listed since September 18, 2020. COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States.

CMPS has shown sold momentum, gaining 4.43% over the past week and 12.12% over the past quarter, though year-to-date performance is up 5.94%. Short-term trend indicators are bearishly aligned (SMA20 5.69%, SMA50 5.79%, SMA200 35.28%). The stock’s 14-day RSI is 52.64 (neutral), while the ATR of 0.65 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -17.64% below its high and over 225.78% above its low. Average 10-day trading volume of 2.62 million shares is below the 3-month average of 4.03 million, indicating normal recent market interest.

COMPASS Pathways plc last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.38. This means the shares are trading above this model’s fair value.

Wall Street analysts project EPS growth of 9.72% annually over the next five years. The latest quarter delivered EPS of -$0.30. The next quarter is forecast at -$0.40. Next year's EPS is expected at -$2.31. Analyst sentiment is bullish. Analyst rating data shows there are 7 Strong Buy ratings, 13 Buy ratings, 1 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $70.00 to $6.00. The high target offers 454.24% upside. The low target suggests -52.49% downside. The mean target is $24.19. This offers 91.53% upside. COMPASS Pathways plc earnings surprise history is a mixed track record. The quarter that ended May 13, 2026, missed forecasts by -33.33%. The prior quarter beat by 43.9%. Over the last six quarters, Apple has recorded several small beats. These include 1.61% in February 27, 2025.

COMPASS Pathways plc has 95.94 million shares outstanding. The public float is 58.41 million shares, elevated short interest at 8.26% of float. This equals 7.78 million shares. The short ratio is 4.18 days. Institutional investors hold 64.17% of the float. Insiders own 13.3%. ATAI Life Sciences N.V. holds 6.91 million shares, Malievskaia Ekaterina has 3.15 million shares and Goldsmith George Jay has 3.15 million shares.

COMPASS Pathways plc trades at a P/E ratio of -5.84, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 4.23 trading at moderately above to book value. The P/FCF stands at -7.56, also above market averages.

Our AI price prediction model suggests that COMPASS Pathways plc stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -2.3%, with price expected at $12.34 by July 06, 2026, within a range of $11.63 to $13.10 3-Month Outlook: Projected rise of 32.62%, reaching $16.75 by September 16, 2026, with a range of $16.36 to $17.17. 1-Year Outlook: Projected gain of 244.58%, with price at $43.52 by June 22, 2027, within a range of $45.77 to $53.23.

COMPASS Pathways plc (NASDAQ:CMPS) shares are flat 5.94% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows COMPASS Pathways plc trading at a premium to the broader market with a P/E of -5.84. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $43.41, suggesting 243.71% upside. Our AI forecast model points to short-term weakness (-2.3% over two weeks), a medium-term rise (32.62% over three months), and a longer-term gain (244.58% over one year), with expected trading ranges indicating moderate volatility.